Efficacité et innocuité des agents antiviraux contre le SRAS-CoV-2, selon des données d’études sur la COVID-19 et d’autres infections virales aiguës : revue systématique et méta-analyse
| dc.contributor.author | Liu W | |
| dc.contributor.author | Zhou P | |
| dc.contributor.author | Chen K | |
| dc.contributor.author | Ye Z | |
| dc.contributor.author | Liu F | |
| dc.contributor.author | Li X | |
| dc.contributor.author | He N | |
| dc.contributor.author | Wu Z | |
| dc.contributor.author | Zhang Q | |
| dc.contributor.author | Gong X | |
| dc.contributor.author | Tang Q | |
| dc.contributor.author | Du X | |
| dc.contributor.author | Ying Y | |
| dc.contributor.author | Xu X | |
| dc.contributor.author | Zhang Y | |
| dc.contributor.author | Liu J | |
| dc.contributor.author | Li Y | |
| dc.contributor.author | Shen N | |
| dc.contributor.author | Couban RJ | |
| dc.contributor.author | Ibrahim QI | |
| dc.contributor.author | Guyatt G | |
| dc.contributor.author | Zhai S | |
| dc.date.accessioned | 2021-06-08T15:24:57Z | |
| dc.date.available | 2021-06-08T15:24:57Z | |
| dc.date.issued | 2020-11-23 | |
| dc.date.updated | 2021-06-08T15:24:56Z | |
| dc.identifier.doi | https://doi.org/10.1503/cmaj.200647-f | |
| dc.identifier.issn | 0820-3946 | |
| dc.identifier.issn | 1488-2329 | |
| dc.identifier.uri | http://hdl.handle.net/11375/26519 | |
| dc.publisher | CMA Joule Inc. | |
| dc.rights | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND This license is the most restrictive of the main Creative Commons licenses, only allowing others to download your works and share them with others as long as they credit you, but they can?t change them in any way or use them commercially. | |
| dc.rights.license | Attribution-NonCommercial-NoDerivs - CC BY-NC-ND | |
| dc.rights.uri | 7 | |
| dc.subject | Antiviral Agents | |
| dc.subject | COVID-19 | |
| dc.subject | Humans | |
| dc.subject | Pandemics | |
| dc.subject | SARS-CoV-2 | |
| dc.subject | Treatment Outcome | |
| dc.title | Efficacité et innocuité des agents antiviraux contre le SRAS-CoV-2, selon des données d’études sur la COVID-19 et d’autres infections virales aiguës : revue systématique et méta-analyse | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- E1585.full.pdf
- Size:
- 372.06 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version